Objectives: Both antibody and cell-mediated immune responses are involved in the defence against influenza. Although antibody responses are unaltered in Wegener’s granulomatosis (WG), the level of cell-mediated responses to vaccination could be deficient.
Methods: Twenty-five WG patients and healthy controls received subunit influenza vaccine. PBMCs were obtained before and one month after vaccination. Cell-mediated responses to A/H1N1 and A/H3N2 were assessed using interferon-γ (IFN-γ) ELISpot and intracellular cytokine staining for IFN-γ, tumour necrosis factor (TNF) and interleukin-2 (IL-2).
Results: Prior to vaccination, patients and controls showed similar recall responses to A/H1N1 and A/H3N2. Following vaccination, patients and controls showed similar levels of increase in spot-forming cells against A/H1N1 and A/H3N2. By flow cytometry, upon vaccination, proportions of cytokine-producing CD4+ T-cells increased in patients and controls for A/H1N1 and A/H3N2.
Conclusions: Cell-mediated responses to influenza vaccination in WG patients are comparable to those in healthy controls. Dutch Trials Register, NTR1130.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.